U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Wang K, Tonner S, Semple MG, et al. The early use of Antibiotics for At-risk children with InfluEnza in Primary Care (the ARCHIE programme). Southampton (UK): National Institute for Health and Care Research; 2023 May. (Programme Grants for Applied Research, No. 11.01.)

Cover of The early use of Antibiotics for At-risk children with InfluEnza in Primary Care (the ARCHIE programme)

The early use of Antibiotics for At-risk children with InfluEnza in Primary Care (the ARCHIE programme).

Show details

Research programme

An effective, evidence-based, policy on antibiotic use in at-risk children during influenza season is needed to ensure that national antibiotic stockpiles are used in the most clinically appropriate and cost-effective way while adhering to responsible antimicrobial stewardship.

The ARCHIE programme (early use of Antibiotics for at-Risk CHildren with InfluEnza) consists of five inter-related work packages, shown in Figure 1, and nine objectives. We present a summary of each work package that inform our conclusions and their implications.

FIGURE 1. Inter-relationship of work packages.

FIGURE 1

Inter-relationship of work packages.

At the end of each work package summary is further detail on how it links to the others and how each work package contributed to the main implications of our work.

The management arrangements for the programme are detailed in Appendix 1.

Work package A: systematic review

Objective 1: identify risk factors and assess the reliability of published prognostic models for influenza-related complications in children.

Work package B: qualitative work

Objective 2: understand what factors influence GPs’ decisions about antibiotic prescribing for at-risk children with influenza/ILI.

Objective 3: explore the experiences of parents of at-risk children who have previously become unwell owing to influenza/ILI and

Objective 4: explore parental consulting attitudes in relation to influenza/ILI and involve parents of at-risk children in the development of trial materials.

Work package C: randomised controlled trial

Objective 5: determine the effectiveness of early co-amoxiclav use in at-risk children with influenza/ILI.

Work package D: microbiology

Objective 6 examine the impact on antibiotic resistance of early co-amoxiclav use in at-risk children with influenza/ILI.

Objective 7 determine the impact on long-term respiratory bacterial carriage of early co-amoxiclav use in at-risk children with influenza/ILI.

Work package E: risk reduction scores and health economics

Objective 8: develop and validate risk scores for influenza-related clinical deterioration and complications for use in children with influenza/ILI (work package E1).

Objective 9: explore the cost-effectiveness of different potential strategies for early antibiotic use in at-risk children with influenza/ILI (work package E2).

Copyright © 2023 Wang et al.

This work was produced by Wang et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

Bookshelf ID: NBK594223

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.5M)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...